Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Hemo

<< Previous

Bullboard Posts

Next >>

Comment by krikoon Jun 30, 2021 3:18pm

118 Views

Post# 33474397

RE:RE:Hemo

The password was sernova2021. It was in the AGM Circular, which was buried on SVA website.

However, even with a Control Number and password, I could not authenticate to the meeting - tried several times and with different browsers. Finally ended up logging in as Guest.

I knew there had to be technical issues given that there were supposedly no questions as well as how fast the meeting wrapped.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario